Portfolio Companies

Adello Biologics [fka Therapeutic Proteins]

Adello Biologics is a biosimilar company focused on developing complex biologics for major regulated and strategic markets globally. Adello leverages single-use technology to operate nimbly while making biosimilar medications affordable.

Always in Touch [aka OnKöl]

OnKöl is a simple-to-use invention that connects elderly and those with special needs to their family and caregivers. It provides a team approach to helping care for a loved one, while allowing them to continue to live independently in their home.

Centron

Centron’s fuel enhancers boost gasoline and diesel mileage and eliminate undesirable emissions, including nitrous oxides and volatile organic compounds.

CytoPherx

CytoPherx has developed a patented hollow-fiber dialysis filter that sequesters and deactivates white blood cells to treat inflammation.

EpiCare

EpiCare focuses on the development and sale of skin care and wound care products.

Gemphire Therapeutics (NASDAQ: GEMP)

Gemphire Therapeutics is developing gemcabene, a once-daily oral therapy, for patients who are unable to achieve normal levels of LDL ("bad") cholesterol or triglycerides with currently approved therapies, primarily statin therapy. Gemcabene’s dual mechanism of action is designed to both inhibit the production of fatty acids and cholesterol in the liver and enhances the clearance of very low-density lipoproteins in plasma.

HarQen

HarQen is a web telephony company that uses its voice-to-web audio technology and social networking platform for business applications

Intellihot

Intellihot designs and manufactures more efficient, intelligent water heating and delivery systems that are powerful enough to handle the extreme loads of commercial and industrial applications, and precise enough to manage the unique demands of residential properties.

LiquidCool Solutions [fka Hardcore Computer]

LiquidCool Solutions has developed a proprietary technology that uses patented liquid submersion cooling to remove heat from computer hardware and other electronic devices.

NanoStatics

NanoStatics provides solutions for the development of high performance materials in a broad scope of product applications through the practical use of nanofibers in a manufacturing environment.

Ocularis Pharma

To address the problem of night vision complaints due to light scatter, Ocularis has patented the use of an entire class of molecules that have been demonstrated to inhibit pupil dilation in dim light.

OPS Solutions [aka Light Guide Systems]

OPS Solutions sells its patented Light Guide Systems™ to manufacturing companies, providing the combination of proprietary software and advanced projection technology to provide step-by-step directions for manual operations.

PEGEX

PEGEX offers a platform for small and medium waste producers to cost-efficiently dispose of their waste.

Physician Software Systems

Physician Software Systems is a software-as-a-service system to more accurately dose erythropoiesis-stimulating agents (ESAs) for treating anemia in dialysis patients.

PreEmptive Meds (PMI)

PMI’s products represent viable options for preempting disease or assisting in medical treatment and are supported by meaningful clinical data.

Prevacept Infection Control [fka Great Lakes Pharmaceuticals]

Prevacept Infection Control is a clinical stage company focused on development and commercialization of products designed to prevent infections associated with indwelling catheters.

Rapid Diagnostek

Rapid Diagnostek has developed a patented, point-of-care, biosensor-based platform appropriate for detecting proteins, bacteria, viruses, and other substances contained in liquid samples.

ScholarCentric

ScholarCentric’s Success Highways™ program is the only university researched drop-out prevention program in the K-12 market and was developed by Dr. Scott Solberg at the University of Wisconsin in a multi-year study that identified the failure factors and developed a program for at-risk students to achieve success.

Sierra Oncology (NASDAQ: SRRA) [fka ProNAi Therapeutics (NASDAQ: DNAI)]

Sierra Oncology is a clinical-stage company advancing a pipeline of promising therapies that target the DNA Damage Response (DDR) network.